Oxford Medical Simulation (OMS), a company developing virtual reality training tools for healthcare professionals, has raised €5.78 million (£5 million) in growth funding.
The investment was provided by Salica Investments, a UK firm that backs high-growth companies across Europe. The new capital will support OMS’s expansion into the United States while strengthening its technology platform for clinical training.
What The Company Does
Founded in 2017 by Michael Wallace and Dr. Jack Pottle, Oxford Medical Simulation develops virtual reality training systems designed for clinicians and medical students.
The company’s platform uses VR headsets to simulate clinical environments where learners can practice diagnosing and treating patients in interactive scenarios. These simulations allow users to experience realistic healthcare situations without the risks associated with real-world training.
Participants can repeat exercises, make decisions during simulated medical cases, and receive detailed feedback on their performance. The platform aims to help healthcare professionals refine clinical judgment and procedural skills in a controlled environment.
OMS integrates artificial intelligence to create dynamic scenarios that adapt to user decisions, enabling personalized learning experiences and more realistic training simulations.
Advertisement
Market Context / Industry Background
Healthcare systems rely heavily on simulation-based training to prepare clinicians for complex medical situations.
Traditional training methods often involve physical simulation labs, which can be expensive to operate and may limit the number of scenarios trainees can experience. Virtual reality platforms are increasingly being explored as an alternative that can deliver scalable and repeatable training environments.
By using immersive technology, VR training tools can recreate emergency situations, clinical decision-making processes, and patient interactions in ways that allow healthcare workers to practice repeatedly without risk to patients.
Medical schools and hospitals are gradually integrating digital simulation tools into training programs as part of broader efforts to modernize clinical education and improve patient safety.
Founder / Investor Commentary
Michael Wallace, CEO and co-founder of Oxford Medical Simulation, said the new investment will support the company’s next phase of growth.
“This financing allows us to invest confidently in the next phase of OMS,” Wallace said.
He noted that healthcare organizations are increasingly focused on improving training outcomes and preparing clinicians more effectively for real-world practice.
“With this growth capital from Salica, we can expand our content library, deepen our analytics capabilities, and support more institutions that want to modernize how clinical training is delivered,” Wallace added.
Usman Ali, partner at one of Salica’s investment funds, said the company addresses a critical need within healthcare education.
“The team has built a differentiated platform that is already working with leading health systems and universities,” Ali said. “Their technology provides clinicians and students with opportunities to practice safely before treating patients.”
Growth Plans / Use Of Funds
Oxford Medical Simulation plans to use the funding to expand its presence in the United States by partnering with healthcare systems and academic institutions.
The company also intends to invest in developing new AI-driven training scenarios and improving the platform’s learning analytics tools.
Additional resources will be allocated to strengthening the platform’s infrastructure and workflow features to support larger healthcare organizations adopting VR-based training.
The company previously raised €10.9 million in a Series A funding round in 2024 led by Frog Capital, following earlier investment from ACF Investors.
About Oxford Medical Simulation
Oxford Medical Simulation is a healthcare technology company that develops virtual reality training platforms for clinicians and medical students. Founded in 2017 and based in the United Kingdom, the company combines clinical expertise with AI-driven simulation technology to create immersive medical training scenarios. Its platform enables healthcare professionals to practice clinical decision-making, improve procedural skills, and gain experience in realistic patient care environments.
